A clinical practice improvement project on inappropriate intravenous phosphate replacement

Oral replacement is generally adequate for mild and moderate hypophosphataemia >0.3 mmol/L).1,2 Intravenous (IV) phosphate replacement carries many potential side effects and is therefore given for severe hypophosphataemia (

Saved in:
Bibliographic Details
Published in:Clinical medicine (London, England) England), 2020-03, Vol.20 (2), p.s80-s81
Main Authors: Chaozer, Er, Tay, Joelynn Qiao Bin, Tan, Hejing, Aw, Clarissa Hui Wen, Cheong, Nicholas Wong Wai, Tahir, Nurul Atiqa Binte Mohd
Format: Article
Language:English
Subjects:
Clinical medicine
Nurses
Patient safety
Pharmacists
Physicians
Quality Improvement and Patient Safety
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oral replacement is generally adequate for mild and moderate hypophosphataemia >0.3 mmol/L).1,2 Intravenous (IV) phosphate replacement carries many potential side effects and is therefore given for severe hypophosphataemia (
ISSN:1470-2118
1473-4893
DOI:10.7861/clinmed.20-2-s80